1-16 of 16
Daniel Rea
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract PO5-01-11: Breast Cancer Index and comparative analysis of late distant recurrence risk with results from the TEAM trial

John MS Bartlett, Yi Zhang, Gregory Pond, Jenna Wong, Keying Xu, Melanie Spears, Elizabeth Mallon, Karen Taylor, Annette Hasenburg, Christos Markopoulos, Luc Dirix, Caroline Seynaeve, Cornelis J.H. van de Velde, Daniel Rea, Adam Brufsky, Olle Stål, Dennis Sgroi, Catherine Schnabel, Kai Treuner, Jane Bayani
Journal: Cancer Research
Cancer Res (2024) 84 (9_Supplement): PO5-01-11.
https://doi.org/10.1158/1538-7445.SABCS23-PO5-01-11
Published: 02 May 2024
View article titled, Abstract PO5-01-11: Breast Cancer Index and comparative analysis of late distant recurrence risk with results from the TEAM trial
Journal Articles

Abstract PO4-18-09: SMALL: Open Surgery versus Minimally invasive vacuum-Assisted excision for smaLL screen-detected breast cancer – a UK phase III randomised multi-centre trial

Stuart McIntosh, Charlotte Coles, David Dodwell, Kenneth Elder, Jessica Foster, Claire Gaunt, Amanda Kirkham, Iain Lyburn, Sangeetha Paramasivan, Jenna Morgan, Sarah Pinder, Shelley Potter, Tracy Roberts, Nisha Sharma, Hilary Stobart, Elizabeth Southgate, Sian Taylor-Phillips, Matthew Wallis, Daniel Rea
Journal: Cancer Research
Cancer Res (2024) 84 (9_Supplement): PO4-18-09.
https://doi.org/10.1158/1538-7445.SABCS23-PO4-18-09
Published: 02 May 2024
View article titled, Abstract PO4-18-09: SMALL: Open Surgery versus Minimally invasive vacuum-Assisted excision for smaLL screen-detected breast cancer – a UK phase III randomised multi-centre trial
Journal Articles

Abstract OT3-20-02: SMALL: Open Surgery versus Minimally invasive vacuum-Assisted excision for smaLL screen-detected breast cancer – a UK phase III randomised multi-centre trial

Stuart A. McIntosh, Charlotte E. Coles, David Dodwell, Kenneth Elder, Jessica Foster, Claire Gaunt, Amanda Kirkham, Iain Lyburn, Jenna Morgan, Sangeetha Paramasivan, Sarah E. Pinder, Sarah Pirrie, Shelley Potter, Tracy Roberts, Nisha Sharma, Hilary Stobart, Elizabeth Southgate, Sian Taylor-Phillips, Matthew Wallis, Daniel Rea
Journal: Cancer Research
Cancer Res (2023) 83 (5_Supplement): OT3-20-02.
https://doi.org/10.1158/1538-7445.SABCS22-OT3-20-02
Published: 01 March 2023
View article titled, Abstract OT3-20-02: SMALL: Open Surgery versus Minimally invasive vacuum-Assisted excision for smaLL screen-detected breast cancer – a UK phase III randomised multi-centre trial
Journal Articles

Abstract OT3-32-01: OPTIMA, a prospective randomized trial to validate the clinical utility and cost-effectiveness of gene expression test-directed chemotherapy decisions in high clinical risk early breast cancer

Robert Stein, Andreas Makris, Iain Macpherson, Luke Hughes-Davies, Andrea Marshall, Georgina Dotchin, David A. Cameron, Belinda E. Kiely, Caroline Wilson, Anne Armstrong, Helena M. Earl, Christopher J. Poole, Janice Tsang, Bjørn Naume, Daniel Rea, Hege Ohnstad, Peter S. Hall, Stuart A. McIntosh, Bethany Shinkins, Christopher McCabe, Adrienne Morgan, John MS Bartlett, Janet A. Dunn
Journal: Cancer Research
Cancer Res (2023) 83 (5_Supplement): OT3-32-01.
https://doi.org/10.1158/1538-7445.SABCS22-OT3-32-01
Published: 01 March 2023
View article titled, Abstract OT3-32-01: OPTIMA, a prospective randomized trial to validate the clinical utility and cost-effectiveness of gene expression test-directed chemotherapy decisions in high clinical risk early breast cancer
Journal Articles

Abstract P2-11-10: Validation of the Breast Cancer Index (BCI) prognostic models optimized for late distant recurrence in postmenopausal women with early-stage HR+ breast cancer in the TEAM trial

John MS Bartlett, Keying Xu, Jenna Wong, Gregory R. Pond, Yi Zhang, Melanie Spears, Ranelle Salunga, Elizabeth Mallon, Karen J. Taylor, Annette Hasenburg, Christos Markopoulos, Luc Dirix, Caroline Seynaeve, Cornelis J.H. van de Velde, Daniel Rea, Catherine A. Schnabel, Kai Treuner, Jane Bayani
Journal: Cancer Research
Cancer Res (2023) 83 (5_Supplement): P2-11-10.
https://doi.org/10.1158/1538-7445.SABCS22-P2-11-10
Published: 01 March 2023
View article titled, Abstract P2-11-10: Validation of the Breast Cancer Index (BCI) prognostic models optimized for late distant recurrence in postmenopausal women with early-stage HR+ breast cancer in the TEAM trial
Journal Articles

Abstract P6-05-17: Recruitment challenges in a UK surgical de-escalation study: preliminary qualitative research findings from the SMALL trial

Stuart A. McIntosh, Charlotte E. Coles, David Dodwell, Kenneth Elder, Jessica Foster, Claire Gaunt, Amanda Kirkham, Iain Lyburn, Jenna Morgan, Sarah E. Pinder, Sarah Pirrie, Shelley Potter, Tracy Roberts, Nisha Sharma, Hilary Stobart, Elizabeth Southgate, Sian Taylor-Phillips, Matthew Wallis, Daniel Rea, Sangeetha Paramasivan
Journal: Cancer Research
Cancer Res (2023) 83 (5_Supplement): P6-05-17.
https://doi.org/10.1158/1538-7445.SABCS22-P6-05-17
Published: 01 March 2023
View article titled, Abstract P6-05-17: Recruitment challenges in a UK surgical de-escalation study: preliminary qualitative research findings from the SMALL trial
Journal Articles

Abstract PD14-08: Effectiveness of aromatase inhibitors versus tamoxifen in lobular compared to ductal carcinoma: Individual patient data meta-analysis of 9328 women with central histopathology, and 7654 women with e-Cadherin status

Robert K Hills, Steffi Oesterreich, Otto Metzger, David Dabbs, Hongchao Pan, Jeremy Braybrooke, Richard Gray, Richard Peto, Rosie Bradley, Ewan Straiton, Richard Berry, Daniel Rea, David Cameron, Jack Cuzick, Meredith Regan, Mitch Dowsett, Ivana Sestak, Jonas Bergh, Sandra M Swain, John Bartlett, Early Breast Cancer Trialists' Collaborative Group
Journal: Cancer Research
Cancer Res (2022) 82 (4_Supplement): PD14-08.
https://doi.org/10.1158/1538-7445.SABCS21-PD14-08
Published: 15 February 2022
View article titled, Abstract PD14-08: Effectiveness of aromatase inhibitors versus tamoxifen in lobular compared to ductal carcinoma: Individual patient data meta-analysis of 9328 women with central histopathology, and 7654 women with e-Cadherin status
Journal Articles

Abstract OT1-06-02: SMALL - Open surgery versus minimally invasive vacuum-assisted excision for small screen detected breast cancer: A phase 3 randomised trial

Stuart A McIntosh, Charlotte E Coles, Carmel Conefrey, David Dodwell, Kenneth Elder, Jessica Foster, Claire Gaunt, Amanda Kirkham, Iain Lyburn, Jenna Morgan, Sangeetha Paramasivan, Sarah Pinder, Sarah Pirrie, Shelley Potter, Tracy Roberts, Nisha Sharma, Hilary Stobart, Elizabeth Southgate, Sian Taylor-Phillips, Matthew Wallis, Daniel Rea
Journal: Cancer Research
Cancer Res (2022) 82 (4_Supplement): OT1-06-02.
https://doi.org/10.1158/1538-7445.SABCS21-OT1-06-02
Published: 15 February 2022
View article titled, Abstract OT1-06-02: SMALL - Open surgery versus minimally invasive vacuum-assisted excision for small screen detected breast cancer: A phase 3 randomised trial
Journal Articles

Abstract GS3-06: Results from the plasmaMATCH trial: A multiple parallel cohort, multi-centre clinical trial of circulating tumour DNA testing to direct targeted therapies in patients with advanced breast cancer (CRUK/15/010)

Nicholas Turner, Belinda Kingston, Lucy Kilburn, Sarah Kernaghan, Andrew M Wardley, Iain Macpherson, Richard D Baird, Rebecca Roylance, Peter Stephens, Olga Oikonomidou, Jeremy P Braybrooke, Mark Tuthill, Jacinta Abraham, Matthew C Winter, Hannah Bye, Michael Hubank, Claire Snowdon, Daniel Rea, David Cameron, Abeer Shaaban, Katrina Randle, Katie Wilkinson, Laura Moretti, Judith M Bliss, Alistair Ring, on behalf of the plasmaMATCH Trial Management Group
Journal: Cancer Research
Cancer Res (2020) 80 (4_Supplement): GS3-06.
https://doi.org/10.1158/1538-7445.SABCS19-GS3-06
Published: 15 February 2020
View article titled, Abstract GS3-06: Results from the plasmaMATCH trial: A multiple parallel cohort, multi-centre clinical trial of circulating tumour DNA testing to direct targeted therapies in patients with advanced breast cancer (CRUK/15/010)
Journal Articles

Abstract P2-11-02: Breast Cancer Index predicts benefit from extended endocrine therapy in HR+ breast cancer

John Bartlett, Dennis Sgori, Kai Treuner, Yi Zhang, Tammy Piper, Ranelle Shalunga, Ikhlaaq Ahmed, Lucy Doos, Sarah Thornber, Elena Brachtel, Sarah Pirrie, Catherine Schnabel, Daniel Rea
Journal: Cancer Research
Cancer Res (2020) 80 (4_Supplement): P2-11-02.
https://doi.org/10.1158/1538-7445.SABCS19-P2-11-02
Published: 15 February 2020
View article titled, Abstract P2-11-02: Breast Cancer Index predicts benefit from extended endocrine therapy in HR+ breast cancer
Journal Articles

Abstract 3259: When is cancer not really cancer: The PREvent Ductal Carcinoma In Situ Invasive Overtreatment Now (PRECISION)* initiative

Jelle Wesseling, Alastair M. Thompson, Serena Nik-Zainal, Andrew Futreal, Shelley Hwang, Jos Jonkers, Esther H. Lips, Daniel Rea
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 3259.
https://doi.org/10.1158/1538-7445.AM2018-3259
Published: 01 July 2018
View article titled, Abstract 3259: When is cancer not really cancer: The PREvent Ductal Carcinoma In Situ Invasive Overtreatment Now (PRECISION)* initiative
Journal Articles

Abstract PD2-3: ARTemis: A randomised trial of bevacizumab with neo-adjuvant chemotherapy for patients with HER2-negative early breast cancer

Helena M Earl, Louise Hiller, Janet A Dunn, Clare Blenkinsop, Louise Grybowicz, Anne-Laure Vallier, Jean Abraham, Jeremy Thomas, Elena Provenzano, Luke Hughes-Davies, Karen McAdam, Stephen Chan, Rizvana Ahmad, Tamas Hickish, Stephen Houston, Daniel Rea, John Bartlett, Carlos Caldas, David Cameron, Larry Hayward
Journal: Cancer Research
Cancer Res (2015) 75 (9_Supplement): PD2-3.
https://doi.org/10.1158/1538-7445.SABCS14-PD2-3
Published: 01 May 2015
View article titled, Abstract PD2-3: ARTemis: A randomised trial of bevacizumab with neo-adjuvant chemotherapy for patients with HER2-negative early breast cancer
Journal Articles

Abstract P4-11-09: Comparison of immunohistochemical residual risk panels to predict risk in early breast cancers treated with endocrine therapy

Jacqueline Stephen, Gordon Murray, David Cameron, Jeremy Thomas, Ian Kunkler, Wilma Jack, Gill Kerr, Tammy Piper, Cassandra Brookes, Daniel Rea, Cornelis van de Velde, Annette Hasenburg, Christos Markopoulos, Luc Dirix, Caroline Seynaeve, John Bartlett
Journal: Cancer Research
Cancer Res (2015) 75 (9_Supplement): P4-11-09.
https://doi.org/10.1158/1538-7445.SABCS14-P4-11-09
Published: 01 May 2015
View article titled, Abstract P4-11-09: Comparison of immunohistochemical residual risk panels to predict risk in early breast cancers treated with endocrine therapy
Journal Articles

Abstract P4-11-10: Time dependence of biomarkers: Non-proportional effects of immunohistochemical panels predicting relapse risk in early breast cancer

Jacqueline Stephen, Gordon Murray, David Cameron, Jeremy Thomas, Ian Kunkler, Wilma Jack, Gill Kerr, Tammy Piper, Cassandra Brookes, Daniel Rea, Cornelis van de Velde, Annette Hasenburg, Christos Markopoulos, Luc Dirix, Caroline Seynaeve, John Bartlett
Journal: Cancer Research
Cancer Res (2015) 75 (9_Supplement): P4-11-10.
https://doi.org/10.1158/1538-7445.SABCS14-P4-11-10
Published: 01 May 2015
View article titled, Abstract P4-11-10: Time dependence of biomarkers: Non-proportional effects of immunohistochemical panels predicting relapse risk in early breast cancer
Journal Articles

Effects of an Exon 5 Variant of the Estrogen Receptor in MCF-7 Breast Cancer Cells

Daniel Rea, Malcolm G. Parker
Journal: Cancer Research
Cancer Res (1996) 56 (7): 1556–1563.
Published: 01 April 1996
View article titled, Effects of an Exon 5 Variant of the Estrogen Receptor in MCF-7 Breast Cancer Cells
Open the PDF for Effects of an Exon 5 Variant of the Estrogen Receptor in MCF-7 Breast Cancer Cells in another window
Journal Articles

A Phase I Study of the Left-shifting Agent BW12C79 plus Mitomycin C and the Effect on the Skeletal Muscle Metabolism Using 31P Magnetic Resonance Spectroscopy

Philip A. Philip, Campbell H. Thompson, James Carmichael, Daniel Rea, Karen Mitchell, Doris J. Taylor, Nicholas S. A. Stuart, Ian Dennis, B. Rajagopalan, Trivadi Ganesan, George K. Radda, Adrian L. Harris
Journal: Cancer Research
Cancer Res (1993) 53 (23): 5649–5653.
Published: 01 December 1993
View article titled, A Phase I Study of the Left-shifting Agent BW12C79 plus Mitomycin C and the Effect on the Skeletal Muscle Metabolism Using <sup>31</sup>P Magnetic Resonance Spectroscopy
Open the PDF for A Phase I Study of the Left-shifting Agent BW12C79 plus Mitomycin C and the Effect on the Skeletal Muscle Metabolism Using <sup>31</sup>P Magnetic Resonance Spectroscopy in another window